Prolastin c 1,000 MG/20 ML VLS

Ended Awarded

Contract number
SPE2DR26FQLZ3
Awardee
Awarding agency
Obligated
$10,387

Award facts

Contract value 100% obligated
$10,387.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $10,387.20 delivery order to DMS Pharmaceutical Group Inc. on June 23, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Prolastin C 1,000 mg/20 ml vials.

DMS Pharmaceutical Group Inc. is a woman-owned small business serving as the regional prime vendor under PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price and an ultimate completion date of July 15, 2026. No set-aside applies.

Quick answers

Who was awarded contract SPE2DR26FQLZ3?

SPE2DR26FQLZ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 23, 2026.

How much is contract SPE2DR26FQLZ3 worth?

The government has obligated $10,387 on SPE2DR26FQLZ3.

Is contract SPE2DR26FQLZ3 an order under another contract?

Yes. SPE2DR26FQLZ3 is a delivery order under SPE2DR25D9354, an indefinite delivery contract.

Was contract SPE2DR26FQLZ3 competed?

The extent of competition for SPE2DR26FQLZ3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award